Skip to content

Neuropathy Evaluation Using the Vibration of a Mobile Phone

Neuropathy Evaluation Using the Vibration Function of a Mobile Phone - the NERVE Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05928013
Acronym
NERVE
Enrollment
328
Registered
2023-07-03
Start date
2023-04-19
Completion date
2024-05-07
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot

Brief summary

A single centre validation/method comparison study of the experimental NERVE device for the measurement of vibration perception threshold against the established 'Neurothesiometer' device, evaluating agreement and reliability. It will also include collecting feedback from patients, carers and clinicians on the usability of the device

Interventions

DIAGNOSTIC_TESTNeurothesiometer

The 'gold standard' device for Vibration Perception Threshold testing

DIAGNOSTIC_TESTNERVE

The experimental device for Vibration Perception Threshold testing developed by the project team

Sponsors

University Hospitals Dorset NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Formally Diagnosed With Diabetes

Exclusion criteria

* 1\. Un- willing or un-able to provide free informed consent (no time limit) * 2\. Un-willing or un-able to comply with all protocol requirements including study assessments; * 3\. Bilateral foot ulcers

Design outcomes

Primary

MeasureTime frameDescription
Vibration Perception Threshold (volts) as measured by Health Care ProfessionalsBaselineMeasured using Neurothesiometer and NERVE device
Vibration Perception Threshold (volts) as measured by person with diabetesBaselineMeasured using NERVE device

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026